Literature DB >> 17891172

An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle.

H J Park1, Z Wang, R H Costa, A Tyner, L F Lau, P Raychaudhuri.   

Abstract

The FoxM1 transcription factor plays critical roles in the expression of genes that are essential for cell proliferation. FoxM1 null or depleted cells fail to progress through mitosis, as expression of several mitotic genes depends upon FoxM1. The transcriptional activity of FoxM1 is stimulated by cyclin-cdk-mediated phosphorylation at a site within the transcriptional activation domain. Here, we characterize the role of an N-terminal inhibitory domain in the transcriptional activity of FoxM1. Deletion of the N-terminal 232 amino-acid residues increases the transcriptional and transforming activities of FoxM1. Moreover, while the activity of the full-length FoxM1 is stimulated by growth factors, the activity of the N-terminal deletion mutant is constitutively high in all phases of the cell cycle. The N-terminal deletion also eliminates the requirement for cyclin-cdk to activate FoxM1. We provide evidence that the N-terminal domain interacts with the C-terminal half of the transcription factor to attenuate its transcriptional activity. Moreover, the N-terminal fragment inhibits the transcriptional activity of FoxM1 in G1/S cells, but not in G2/M cells. Our results suggest that cyclin-cdk phosphorylates FoxM1 to counteract the inhibition by the N-terminal domain to fully activate FoxM1 in G2/M phase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17891172      PMCID: PMC2894537          DOI: 10.1038/sj.onc.1210814

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  Despite its strong transactivation domain, transcription factor FOXM1c is kept almost inactive by two different inhibitory domains.

Authors:  Inken Wierstra; Jürgen Alves
Journal:  Biol Chem       Date:  2006-07       Impact factor: 3.915

2.  A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment.

Authors:  Galina A Gusarova; I-Ching Wang; Michael L Major; Vladimir V Kalinichenko; Timothy Ackerson; Vladimir Petrovic; Robert H Costa
Journal:  J Clin Invest       Date:  2006-12-14       Impact factor: 14.808

3.  FOXM1c is activated by cyclin E/Cdk2, cyclin A/Cdk2, and cyclin A/Cdk1, but repressed by GSK-3alpha.

Authors:  Inken Wierstra; Jürgen Alves
Journal:  Biochem Biophys Res Commun       Date:  2006-07-12       Impact factor: 3.575

4.  Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues.

Authors:  H Ye; T F Kelly; U Samadani; L Lim; S Rubio; D G Overdier; K A Roebuck; R H Costa
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

5.  Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4.

Authors:  Inken Wierstra; Jürgen Alves
Journal:  Biol Chem       Date:  2006-07       Impact factor: 3.915

6.  The winged-helix transcription factor Trident is expressed in cycling cells.

Authors:  W Korver; J Roose; H Clevers
Journal:  Nucleic Acids Res       Date:  1997-05-01       Impact factor: 16.971

7.  Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice.

Authors:  Tanya V Kalin; I-Ching Wang; Timothy J Ackerson; Michael L Major; Carol J Detrisac; Vladimir V Kalinichenko; Alexander Lyubimov; Robert H Costa
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

8.  Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation.

Authors:  J M Lüscher-Firzlaff; J M Westendorf; J Zwicker; H Burkhardt; M Henriksson; R Müller; F Pirollet; B Lüscher
Journal:  Oncogene       Date:  1999-10-07       Impact factor: 9.867

9.  FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells.

Authors:  Mingguang Liu; Bingbing Dai; Shin-Hyuk Kang; Kechen Ban; Feng-Ju Huang; Frederick F Lang; Kenneth D Aldape; Tong-xin Xie; Christopher E Pelloski; Keping Xie; Raymond Sawaya; Suyun Huang
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

10.  Uncoupling of S phase and mitosis in cardiomyocytes and hepatocytes lacking the winged-helix transcription factor Trident.

Authors:  W Korver; M W Schilham; P Moerer; M J van den Hoff; K Dam; W H Lamers; R H Medema; H Clevers
Journal:  Curr Biol       Date:  1998-12-03       Impact factor: 10.834

View more
  42 in total

1.  A Chlamydia-specific C-terminal region of the stress response regulator HrcA modulates its repressor activity.

Authors:  Allan L Chen; Adam C Wilson; Ming Tan
Journal:  J Bacteriol       Date:  2011-09-30       Impact factor: 3.490

2.  High Fat Diet Regulation of β-Cell Proliferation and β-Cell Mass.

Authors:  M L Golson; A Ackermann Misfeldt; U G Kopsombut; C P Petersen; M Gannon
Journal:  Open Endocrinol J       Date:  2010

3.  Protein phosphatase 2A (B55α) prevents premature activation of forkhead transcription factor FoxM1 by antagonizing cyclin A/cyclin-dependent kinase-mediated phosphorylation.

Authors:  Mónica Alvarez-Fernández; Vincentius A Halim; Melinda Aprelia; Jamila Laoukili; Shabaz Mohammed; René H Medema
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

4.  DDB2, an essential mediator of premature senescence.

Authors:  Nilotpal Roy; Tanya Stoyanova; Carmen Dominguez-Brauer; Hyun Jung Park; Srilata Bagchi; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

5.  Metadherin/Astrocyte elevated gene-1 positively regulates the stability and function of forkhead box M1 during tumorigenesis.

Authors:  Lixuan Yang; Kejun He; Sheng Yan; Yibing Yang; Xinya Gao; Maolei Zhang; Zhibo Xia; Zhengsong Huang; Suyun Huang; Nu Zhang
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

6.  Activation of FoxM1 during G2 requires cyclin A/Cdk-dependent relief of autorepression by the FoxM1 N-terminal domain.

Authors:  Jamila Laoukili; Monica Alvarez; Lars A T Meijer; Marie Stahl; Shabaz Mohammed; Livio Kleij; Albert J R Heck; René H Medema
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

7.  FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.

Authors:  J Millour; D Constantinidou; A V Stavropoulou; M S C Wilson; S S Myatt; J M-M Kwok; K Sivanandan; R C Coombes; R H Medema; J Hartman; A E Lykkesfeldt; E W-F Lam
Journal:  Oncogene       Date:  2010-03-08       Impact factor: 9.867

Review 8.  FOX(M1) news--it is cancer.

Authors:  Marianna Halasi; Andrei L Gartel
Journal:  Mol Cancer Ther       Date:  2013-02-26       Impact factor: 6.261

9.  Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression.

Authors:  Qiang Li; Nu Zhang; Zhiliang Jia; Xiangdong Le; Bingbing Dai; Daoyan Wei; Suyun Huang; Dongfeng Tan; Keping Xie
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

10.  FoxM1, a critical regulator of oxidative stress during oncogenesis.

Authors:  Hyun Jung Park; Janai R Carr; Zebin Wang; Veronique Nogueira; Nissim Hay; Angela L Tyner; Lester F Lau; Robert H Costa; Pradip Raychaudhuri
Journal:  EMBO J       Date:  2009-08-20       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.